Suchergebnisse - "Safra, Tamar"

PubPharm (13)

1

ATHENA (GOG-3020/ENGOT-ov45) : a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2021

von Monk, B. | Coleman, R. | Fujiwara, K. | +18

2

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

enthalten in: The New England journal of medicine | 2021

von Colombo, N. | Dubot, C. | Lorusso, D. | +117

CommentIn: Nat Rev Clin Oncol. 2021 Dec;18(12):747. - PMID 34616034

3

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

enthalten in: The New England journal of medicine | 2019

von González-Martín, A. | Pothuri, B. | Vergote, I. | +128

CommentIn: N Engl J Med. 2019 Dec 19;381(25):2471-2474. - PMID 31851805

4

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

enthalten in: The New England journal of medicine | 2019

von André, F. | Ciruelos, E. | Rubovszky, G. | +118

CommentIn: Nat Rev Clin Oncol. 2019 Aug;16(8):466. - PMID 31127192

5

Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy : An Open-label, Phase II Trial

enthalten in: Clinical breast cancer | 2018

von Safra, T. | Kaufman, B. | Kadouri, L. | +5

6

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

enthalten in: The New England journal of medicine | 2016

von Mirza, M. | Monk, B. | Herrstedt, J. | +118

CommentIn: Nat Rev Clin Oncol. 2017 Feb;14 (2):71. - PMID 27958296

7

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy : an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

enthalten in: The Lancet. Oncology | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +15

CommentIn: Lancet Oncol. 2016 Nov;17 (11):1474-1475. - PMID 27819228

8

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation : Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy

enthalten in: Cancer | 2016

von Matulonis, U. | Harter, P. | Gourley, C. | +13

9

Liposome-encapsulated doxorubicin citrate (Myocet) for treatment of recurrent epithelial ovarian cancer : a retrospective analysis

enthalten in: Anti-cancer drugs | 2014

von Eitan, R. | Fishman, A. | Meirovitz, M. | +8

10

Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma : tolerability and efficacy study--the Israeli experience

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2013

von Safra, T. | Berman, T. | Yachnin, A. | +6